Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
17
BAYRY Quote, Financials, Valuation and Earnings
Last price:
$4.91
Seasonality move
:
-1.69%
Day range:
$4.90 - $4.96
52-week range:
$4.86 - $9.79
Dividend yield:
0.6%
P/E ratio:
--
P/S ratio:
0.38x
P/B ratio:
0.57x
Volume:
3M
Avg. volume:
2.1M
1-year change:
-44.2%
Market cap:
$19.3B
Revenue:
$51.6B
EPS (TTM):
-$0.26
Analysts' Opinion
-
Consensus RatingBayer AG has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Bayer AG has an estimated upside of 54.58% from its current price of $4.91.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $4.91.
Fair Value
-
According to the consensus of 0 analysts, Bayer AG has 54.58% upside to fair value with a price target of -- per share.
BAYRY vs. S&P 500
-
Over the past 5 trading days, Bayer AG has underperformed the S&P 500 by -2.92% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bayer AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bayer AG revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Bayer AG reported revenues of $11B.
Earnings Growth
-
Bayer AG earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bayer AG reported earnings per share of -$1.17.
Enterprise value:
12.4B
EV / Invested capital:
0.36x
Price / LTM sales:
0.38x
EV / EBIT:
6.24x
EV / Revenue:
0.24x
PEG ratio (5yr expected):
--
EV / Free cash flow:
2.14x
Price / Operating cash flow:
3.35x
Enterprise value / EBITDA:
1.22x
Gross Profit (TTM):
$28.9B
Return On Assets:
-0.81%
Net Income Margin (TTM):
-2.02%
Return On Equity:
-2.79%
Return On Invested Capital:
-2.23%
Operating Margin:
-38.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $54.2B | $51B | $50.7B | $11.3B | $11B | |
| Gross Profit | $33.8B | $29.6B | $28.9B | $6B | $5.4B | |
| Operating Income | $12.5B | $30M | $10.1B | -$3.9B | -$4.2B | |
| EBITDA | $13B | $11.6B | $10.1B | $1.6B | $1.2B | |
| Diluted EPS | $1.34 | -$1.04 | -$0.26 | -$1.27 | -$1.17 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $46.2B | $37.1B | $37.8B | $39.7B | $37B | |
| Total Assets | $140.3B | $135.2B | $128.8B | $124.1B | $119.4B | |
| Current Liabilities | $42B | $33.3B | $32.6B | $35B | $28B | |
| Total Liabilities | $103.4B | $98.9B | $88B | $88.6B | $85.2B | |
| Total Equity | $37B | $36.3B | $40.8B | $35.5B | $34.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.7B | $2.9B | $8.7B | $2.8B | $2.3B | |
| Cash From Investing | -$3.6B | $354.6M | -$2.6B | -$151.1M | $4.1B | |
| Cash From Financing | -$4.2B | -$424.6M | -$8.2B | -$177.4M | -$5.6B | |
| Free Cash Flow | $4.7B | -$498.8M | $5.8B | $2.1B | $1.6B | |
BAYRY
Sector
Market Cap
$19.3B
$44.6M
Price % of 52-Week High
50.15%
45.71%
Dividend Yield
0.6%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-44.21%
-29.09%
Beta (5-Year)
1.041
0.772
Dividend yield:
0.6%
Annualized payout:
$0.66
Payout ratio:
-12.82%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$5.06
200-day SMA
Sell
Level
$7.11
Bollinger Bands (100)
Sell
Level
5.7 - 7.98
Chaikin Money Flow
Buy
Level
94.9M
20-day SMA
Sell
Level
$5.11
Relative Strength Index (RSI14)
Sell
Level
27.75
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-90.3846
50-day SMA
Sell
Level
$5.94
MACD (12, 26)
Sell
Level
-0.26
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Sell
Level
-93.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.2268)
Buy
Beneish M-Score
(Annual)
Level (-2.8916)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-1.4048)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
Stock Forecast FAQ
In the current month, BAYRY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BAYRY average analyst price target in the past 3 months is --.
-
Where Will Bayer AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bayer AG share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Bayer AG?
Analysts are divided on their view about Bayer AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bayer AG is a Sell and believe this share price will drop from its current level to --.
-
What Is Bayer AG's Price Target?
The price target for Bayer AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BAYRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bayer AG is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BAYRY?
You can purchase shares of Bayer AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bayer AG shares.
-
What Is The Bayer AG Share Price Today?
Bayer AG was last trading at $4.91 per share. This represents the most recent stock quote for Bayer AG. Yesterday, Bayer AG closed at $4.91 per share.
-
How To Buy Bayer AG Stock Online?
In order to purchase Bayer AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
